Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development

The National Cancer Institute (NCI) Division of Cancer Treatment and Diagnosis (DCTD) Developmental Therapeutics Program (DTP) has issued solicitation NCI-DCTD-23-0001 to secure support services for the operation and maintenance of the National Cancer Institute’s Chemotherapeutic Agents Repository (NCI-CAR). This requirement is classified under NAICS 541990, All Other Professional, Scientific, and Technical Services, and PSC R707, SUPPORT- MANAGEMENT: CONTRACT/PROCUREMENT/ACQUISITION SUPPORT. Performance takes place in Rockville, Maryland, and focuses on facilitating the discovery and development of new cancer therapeutic agents for the worldwide research community.

The primary scope of the contract includes supporting compound acquisition for the DTP anticancer pre-clinical drug evaluation program and distributing chemicals to intramural and extramural investigators. The contractor is responsible for providing an informational interface for investigators submitting or requesting research compounds and maintaining a chemical database that tracks chemical, inventor, receiving, and shipping information. Additional duties include systematic record-keeping of archival and current information related to repository activities and the reacquisition of samples for ongoing biological and chemical studies.

The response deadline for this solicitation is 4:00 PM EST on June 13, 2022, as established by Amendment 1. The solicitation was originally published on May 5, 2022, and includes three attachments: a signed SF30 for Amendment 1, a collection of 23 program attachments, and a draft version of the solicitation. Erin Dwyer is the designated point of contact for this procurement.